Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92915102 | 9291510 | 2 | F | 20111116 | 20160923 | 20130515 | 20160929 | EXP | CA-009507513-1111USA03469 | MERCK | 48.05 | YR | M | Y | 100.00000 | KG | 20160929 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92915102 | 9291510 | 1 | PS | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | 1.5 DOSAGE FROM, 4 EVERY 1 DAY | 17555 | 1.5 | DF | TABLET | QID | ||||||
| 92915102 | 9291510 | 2 | SS | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | 1.5 DOSAGE FROM, 4 EVERY 1 DAY | G013001 | 17555 | 1.5 | DF | TABLET | QID | |||||
| 92915102 | 9291510 | 3 | SS | APOMORPHINE HYDROCHLORIDE | APOMORPHINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 92915102 | 9291510 | 4 | C | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | 1 MG, TID | U | 0 | 1 | MG | TABLET | TID | |||||
| 92915102 | 9291510 | 5 | C | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 1 | U | 0 | FILM-COATED TABLET | ||||||||||
| 92915102 | 9291510 | 6 | C | TECTA | PANTOPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, DAILY | U | 0 | 40 | MG | TABLET | QD | |||||
| 92915102 | 9291510 | 7 | C | DICETEL | PINAVERIUM BROMIDE | 1 | Oral | 50 MG, BID | U | 0 | 50 | MG | FILM-COATED TABLET | BID | |||||
| 92915102 | 9291510 | 8 | C | IMOVANE | ZOPICLONE | 1 | Oral | 1 OR 2, HS | U | 0 | TABLET | QD | |||||||
| 92915102 | 9291510 | 9 | C | NASACORT | TRIAMCINOLONE ACETONIDE | 1 | 2 SPRAYS, BID | U | 0 | 110 | UG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92915102 | 9291510 | 1 | Parkinson's disease |
| 92915102 | 9291510 | 3 | Parkinson's disease |
| 92915102 | 9291510 | 4 | Parkinson's disease |
| 92915102 | 9291510 | 6 | Gastrooesophageal reflux disease |
| 92915102 | 9291510 | 8 | Sleep disorder |
| 92915102 | 9291510 | 9 | Rhinitis allergic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92915102 | 9291510 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92915102 | 9291510 | Adverse reaction | |
| 92915102 | 9291510 | Dizziness | |
| 92915102 | 9291510 | Drooling | |
| 92915102 | 9291510 | Drug effect decreased | |
| 92915102 | 9291510 | Insomnia | |
| 92915102 | 9291510 | Irritability | |
| 92915102 | 9291510 | Mood altered | |
| 92915102 | 9291510 | Product substitution issue | |
| 92915102 | 9291510 | Salivary hypersecretion | |
| 92915102 | 9291510 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92915102 | 9291510 | 2 | 20111116 | 0 |